News - Warner Chilcott


Current filters:

Warner Chilcott

Popular Filters

FTC approves final order regarding Actavis’ acquisition of Warner Chilcott

FTC approves final order regarding Actavis’ acquisition of Warner Chilcott


Following a public comment period, the US Federal Trade Commission has approved a final order settling…

ActavisGenericsMergers & AcquisitionsNorth AmericaRegulationReproductiveWarner Chilcott

Zydus Cadila settles Asacol patent litigation in USA


Zydus Cadila, one of India’s largest privately-held pharmaceuticals companies, and affiliate Zydus…

ActavisAsacol HDGastro-intestinalsGenericsNorth AmericaPatentsWarner ChilcottZydus Cadila

Actavis cuts 350 sales staff after acquisition of Warner Chilcott

Actavis cuts 350 sales staff after acquisition of Warner Chilcott


US generics major Actavis (NYSE: ACT) says it has completed the restructuring of its US Specialty Brands…

ActavisFinancialGenericsManagementNorth AmericaUSAWarner Chilcott

US FDA approval for Warner Chilcott's new oral contraceptive


The US Food and Drug Administration have approved the use of a new oral contraceptive from Ireland-based…

ActavisLo Minastrin FeNorth AmericaPharmaceuticalRegulationReproductiveWarner Chilcott

Highs and lows as Actavis 2nd qtr results meet expectations


US generics drug major Actavis (NYSE: ACT) reported its net revenue increased 46.8% to $1.99 billion…

ActavisFinancialGenericsNorth AmericaWarner Chilcott

Generics briefs: Actavis/Warner Chilcott M&A delay; Canasa patent challenge


US generics major Actavis (NYSE: ACT) and Ireland-based Warner Chilcott (Nasdaq: WCRX) have each received…

ActavisAptalis PharmaCanasaGenericsLegalMergers & AcquisitionsMylan LaboratoriesNorth AmericaPatentsWarner Chilcott

Actavis confirms plan to acquire Warner Chilcott, in $8.5 billion deal


US generics major Actavis (NYSE: ACT) revealed today (May 20) that it has entered into a definitive agreement…

ActavisGenericsMergers & AcquisitionsPharmaceuticalWarner ChilcottWomen's Health

Actavis and Warner Chilcott leap on merger talks; possible bid for Adcock Ingram


US generics major Actavis NYSE: ACT) confirmed on Friday (May 10) that it has entered into early stage…

ActavisAdcock IngramFinancialGenericsMergers & AcquisitionsPharmaceuticalWarner Chilcott

FTC files amicus brief on pharma "product hopping"


The USA's Federal Trade Commission revealed yesterday that it has filed an amicus brief before the US…

DoryxGenericsLegalNorth AmericaPharmaceuticalWarner Chilcott

TaiGen gets global nemonoxacin rights


Taiwan’s TaiGen Biotechnology has reached a deal with Ireland-headquartered Warner Chilcott (Nasdaq:…

Antibiotics and Infectious diseasesBiotechnologyLicensingnemonoxacinPharmaceuticalTaiGen BiotecnologyWarner Chilcott

Mylan settles with Warner Chilcott over Femcon


US generic drugmaker Mylan (Nasdaq: MYL) said yesterday that it, along with Famy Care, has entered into…

Femcon FeGenericsLegalMylan LaboratoriesNorth AmericaPatentsRespiratory and PulmonaryWarner Chilcott

Two US FDA advisory panels say osteoporosis drugs need label changes


Experts advising the US Food and Drug Administration have recommended revised labeling for bisphosphonates,…

ActonelAnti-Arthritics/RheumaticsBonvivaFosamaxMerck & CoNorth AmericaPharmaceuticalReclastRegulationRocheWarner Chilcott

Company Spotlight



Back to top